CorVel Co. (NASDAQ:CRVL – Get Free Report) CFO Brandon O’brien sold 3,957 shares of the stock in a transaction on Monday, June 9th. The stock was sold at an average price of $108.46, for a total value of $429,176.22. Following the completion of the sale, the chief financial officer now owns 11,804 shares in the company, valued at approximately $1,280,261.84. The trade was a 25.11% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
CorVel Price Performance
CRVL stock opened at $105.07 on Friday. The business has a 50-day moving average price of $111.79 and a 200 day moving average price of $115.75. The company has a market capitalization of $5.40 billion, a P/E ratio of 61.81 and a beta of 1.02. CorVel Co. has a 1-year low of $79.81 and a 1-year high of $128.61.
CorVel (NASDAQ:CRVL – Get Free Report) last released its quarterly earnings data on Thursday, May 22nd. The business services provider reported $0.51 earnings per share for the quarter. The firm had revenue of $231.51 million during the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.
Institutional Trading of CorVel
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded CorVel from a “hold” rating to a “buy” rating in a report on Friday, April 18th.
Read Our Latest Report on CRVL
About CorVel
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Featured Stories
- Five stocks we like better than CorVel
- Dividend Capture Strategy: What You Need to Know
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- What is the Hang Seng index?
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- Financial Services Stocks Investing
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.